Skip to main content
. 2017 Jun 21;42(13):2567–2574. doi: 10.1038/npp.2017.106

Table 2. Change in MADRS scores in Treatment Block 1a and Block 2b in Patients with Major Depressive Disorder Receiving an Antidepressant Plus Adjunctive Placebo or Riluzole.

  Placebo/Placebo (N=40) Placebo/Riluzole (N=39) Riluzole/Riluzole (N=25)
Block 1 4.83 (7.85)c 5.77 (7.52) 3.20 (3.86)
Block 2 3.87 (6.49) 0.84 (5.79) 4.13 (6.82)
a

Baseline to week 4.

b

Week 4 to week 8, among non-responders to placebo in Block 1.

c

Mean (SD).